← 治験一覧に戻る
加齢黄斑変性症に対する光線力学的療法単独療法と硝子体内ベバシズマブ併用療法の比較
基本情報
- NCT ID
- NCT01032109
- ステータス
- 完了
- 試験のフェーズ
- 該当なし
- 試験タイプ
- 介入
- 目標被験者数
- 45
- 治験依頼者名
- Kumamoto University
概要
The purpose of this study is to compare 12-month results of two single initial treatments-photodynamic therapy with verteporfin alone and this therapy combined with intravitreal bevacizumab-for neovascular age-related macular degeneration, not including patients with polypoidal choroidal vasculopathy who were presumed to have age-related macular degeneration.
対象疾患
Age-related Macular Degeneration
介入
Bevacizumab(DRUG)
依頼者(Sponsor)
Kumamoto University(OTHER)
実施施設 (1)
井草眼科医院
Kumamoto, Japan